Reference
Rintoul RC, et al. Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective. Thorax : 24 Sep 2013. Available from: URL: http://dx.doi.org/10.1136/thoraxjnl-2013-204374
Rights and permissions
About this article
Cite this article
Endosonography staging cost effective for NSCLC. PharmacoEcon Outcomes News 689, 6 (2013). https://doi.org/10.1007/s40274-013-0791-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0791-x